Poxvirus vaccines: the evolution of an 18th-century vaccine to the 21st century
- PMID: 39537527
- DOI: 10.1016/j.tips.2024.10.015
Poxvirus vaccines: the evolution of an 18th-century vaccine to the 21st century
Abstract
The unprecedented global spread of monkeypox (mpox) has reinvigorated the pursuit of next-generation poxvirus vaccines. Given the success of the mRNA-lipid nanoparticle (LNP) vaccine platform to vaccinate against SARS-CoV-2, candidate poxvirus mRNA vaccines, as recently reported by Zuiani et al. and Mucker et al., demonstrate success in nonhuman primate (NHP) models and provide insights into the basis of the protective immune response.
Keywords: immune profiling; lipid nanoparticle; mRNA; nonhuman primate.
Published by Elsevier Ltd.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
